Literature DB >> 2098923

The pathogenicity of a Philippine isolate of Naegleria sp. in mice: effects of dose levels and routes of infection.

E C Simeon1, F F Natividad, G L Enriquez.   

Abstract

The pathogenicity of a Philippine isolate of Naegleria sp. was evaluated using 3-4 week-old mice as experimental animals. Results showed that only the massive doses of 10(6) and 10(7) amebae/mouse inoculated intranasally could successfully establish ameba infection in the brain and cause death after 2-6 days. The effect of the ameba on the mortality rate of inoculated mice was dose-dependent. The amebae were recovered in the brain when inoculated through intracerebral and intranasal routes and in the lungs, liver, and intestines when administered through intranasal and oral routes. By intraperitoneal inoculation, recovery of amebae was positive in all major organs except in the heart. Intravenous inoculation resulted to positive recovery in the lungs, spleen, liver, and heart. Infectivity of the ameba isolate in major organs was route-dependent.

Entities:  

Mesh:

Year:  1990        PMID: 2098923

Source DB:  PubMed          Journal:  Southeast Asian J Trop Med Public Health        ISSN: 0125-1562            Impact factor:   0.267


  2 in total

1.  Risk for transmission of Naegleria fowleri from solid organ transplantation.

Authors:  S L Roy; R Metzger; J G Chen; F R Laham; M Martin; S W Kipper; L E Smith; G M Lyon; J Haffner; J E Ross; A K Rye; W Johnson; D Bodager; M Friedman; D J Walsh; C Collins; B Inman; B J Davis; T Robinson; C Paddock; S R Zaki; M Kuehnert; A DaSilva; Y Qvarnstrom; R Sriram; G S Visvesvara
Journal:  Am J Transplant       Date:  2013-11-26       Impact factor: 8.086

Review 2.  Epidemiology of free-living amoebae in the Philippines: a review and update.

Authors:  Giovanni D Milanez; Frederick R Masangkay; Gregorio L Martin I; Ma Frieda Z Hapan; Edilberto P Manahan; Jeffrey Castillo; Panagiotis Karanis
Journal:  Pathog Glob Health       Date:  2022-02-03       Impact factor: 3.735

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.